China Pharma Holdings, Inc.CPHINYSE
Loading
EBITDA Margin Over TimeContracting
Percentile Rank47
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Percentile
P47
Within normal range
vs 5Y Ago
-40.8x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM-40.14%+7.5%
2024-43.37%-36144.8%
20230.12%+101.2%
2022-10.34%-532.7%
20212.39%+143.0%
20200.98%+100.6%
2019-159.75%-175.5%
2018-57.99%+50.0%
2017-115.98%-265.1%
2016-31.77%-